IBL: Azo-Combretastatin A4 (cis)
IBL is a Ligand Of Interest in 8QL3 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
8QL3_IBL_B_702 | 40% | 23% | 0.088 | 0.795 | 1.65 | 1.55 | 7 | 8 | 1 | 0 | 100% | 1 |
8QL2_IBL_B_501 | 76% | 52% | 0.066 | 0.9 | 0.52 | 1.33 | - | 4 | 0 | 0 | 100% | 1 |
8QEA_IBL_B_702 | 50% | 28% | 0.081 | 0.83 | 1.63 | 1.29 | 5 | 4 | 1 | 0 | 100% | 1 |
8QL4_IBL_B_702 | 44% | 40% | 0.097 | 0.822 | 1.22 | 1.13 | 2 | 2 | 0 | 0 | 100% | 1 |
8QL9_IBL_B_502 | 13% | 58% | 0.15 | 0.686 | 0.45 | 1.13 | - | 4 | 1 | 0 | 100% | 0.5 |
8QL5_IBL_B_702 | 12% | 40% | 0.128 | 0.649 | 1.22 | 1.13 | 2 | 2 | 0 | 0 | 100% | 0.59 |